Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04279054 · ClinicalTrials.gov registry record · Early Phase 1
Decreased Neuraxial Morphine After Cesarean Delivery
A Early Phase 1 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 87
- Enrollment target
NCT04279054 is a Early Phase 1 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 87 participants.
The verdict
NCT04279054, a Early Phase 1 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to compare 50mcg to 150mcg morphine in epidural for the goal of decreasing side effects of medication with lower dose in patients who receive a QL block
Interventions
- DRUG Morphine Sulfate 150 mcg
- DRUG Morphine Sulfate 50mcg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2023-07-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04279054
The ClinicalTrials.gov registry entry for NCT04279054 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Morphine Sulfate 150 mcg is the first listed.
NCT04279054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04279054 about?
NCT04279054 is a clinical study titled "Decreased Neuraxial Morphine After Cesarean Delivery". The purpose of this study is to compare 50mcg to 150mcg morphine in epidural for the goal of decreasing side effects of medication with lower dose in patients who receive a QL block
What is the current status of trial NCT04279054?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 87 participants. The study started on 2020-09-09. Estimated completion is 2023-07-05.
What interventions are being tested in trial NCT04279054?
The interventions under investigation include: Morphine Sulfate 150 mcg (DRUG), Morphine Sulfate 50mcg (DRUG).
Who is sponsoring clinical trial NCT04279054?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.